SCHEMBL1600690

SCHEMBL1600690

Cn1nnnc1N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
TP53 P04637 2/20 0.45
MAPT P10636 2/20 0.45
P2RX7 Q99572 1/20 0.45
ALDH1A1 P00352 3/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
TSHR P16473 4/20 0.42
CYP2C19 P33261 1/20 0.41
DAGLA Q9Y4D2 1/20 0.39
NPSR1 Q6W5P4 5/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
AOC3 Q16853 1/20 0.37
CHRM2 P08172 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
DRD1 P21728 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8814158 0.75 TSHR (0.40) LMNAP2RX7ALDH1A1TSHRNPSR1
SCHEMBL16783177 0.70 DAGLA (0.50) LMNAALDH1A1KMT2AMEN1TSHR
SCHEMBL4409003 0.69 CNR2 (0.49) LMNAALDH1A1KMT2AMEN1DAGLA
SCHEMBL1599816 0.69 TSHR (0.42) LMNATP53MAPTALDH1A1KMT2A
SCHEMBL20518060 0.67 HIF1A (0.42) MAPTALDH1A1DAGLANPSR1KDM4E
SCHEMBL11634052 0.66 ALDH1A1 (0.73) LMNAALDH1A1TSHRCYP2C19HTT
SCHEMBL15219430 0.66 LMNA (0.69) LMNAMAPTP2RX7ALDH1A1KMT2A
SCHEMBL4849385 0.64 HDAC1 (0.49) LMNATP53MAPTALDH1A1KMT2A
SCHEMBL23746406 0.64 TSPO (0.46) LMNAMAPTALDH1A1KMT2AMEN1
SCHEMBL10733883 0.63 ALDH1A1 (0.68) LMNATP53MAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1994015-B1 DIBENZYL AMINE DERIVATIVES AS CETP INHIBITORS PFIZER PROD INC (US) 2013-04-24 EP disclosed
US-8383660-B2 Dibenzyl amine compounds and derivatives PFIZER INC. (US) 2013-02-26 US disclosed
US-7919506-B2 Dibenzyl amine compounds and derivatives PFIZER INC. (US) 2011-04-05 US disclosed
EP-1996564-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES Pfizer Products Incorporated (US) 2008-12-03 EP disclosed
EP-1994015-A1 DIBENZYL AMINE DERIVATIVES AS CETP INHIBITORS Pfizer Products Inc. (US) 2008-11-26 EP disclosed
WO-2007105050-A1 DIBENZYL AMINE COMPOUNDS AND DERIVATIVES PFIZER PRODUCTS INC. (US) 2007-09-20 WO disclosed
WO-2007105049-A1 DIBENZYL AMINE DERIVATIVES AS CETP INHIBITORS PFIZER PRODUCTS INC. (US) 2007-09-20 WO disclosed
US-20070213314-A1 Dibenzyl Amine Compounds and Derivatives PFIZER INC 2007-09-13 US disclosed
US-20070213371-A1 Dibenzyl Amine Compounds and Derivatives PFIZER INC 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213314-A1 Dibenzyl Amine Compounds and Derivatives APOB, LDLR, CETP LMNA 584/4885TP53 4534/4885MAPT 539/4885
US-20070213371-A1 Dibenzyl Amine Compounds and Derivatives APOB, LDLR, CETP LMNA 584/4885TP53 4534/4885MAPT 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.